Cargando…
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections
Monoclonal antibodies (mAbs) have wide clinical utility, but global access is limited by high costs and impracticalities associated with repeated passive administration. Here, we describe an optimized electroporation-based DNA gene transfer platform technology that can be utilized for production of...
Autores principales: | Andrews, Chasity D., Luo, Yang, Sun, Ming, Yu, Jian, Goff, Arthur J., Glass, Pamela J., Padte, Neal N., Huang, Yaoxing, Ho, David D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633264/ https://www.ncbi.nlm.nih.gov/pubmed/29034261 http://dx.doi.org/10.1016/j.omtm.2017.09.003 |
Ejemplares similares
-
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies
por: Andrews, Chasity D., et al.
Publicado: (2020) -
Engineering multi-specific antibodies against HIV-1
por: Padte, Neal N., et al.
Publicado: (2018) -
Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation
por: Perez, Norma, et al.
Publicado: (2004) -
Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012) -
Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model
por: Miller, Joanna L., et al.
Publicado: (2016)